Banjo Health is developing a prior authorization decision support platform for health plans and pharmacy benefit managers (collectively “payers”). The company leverages artificial intelligence and machine learning to customize the platform to each payer’s specific prior authorization criteria. Through its integration with the provider’s electronic health records, the company is able to directly draw from the prescribers' notes to drive accurate decisions while reducing the administrative burden on the payer’s and provider’s staff. This will effectively reduce the time-to-decision, improving member satisfaction and clinical and cost outcomes. Banjo Health was founded in 2019 and is based in Washington, DC.

Q Bio builds technology that quantifies, digitizes, and simulates human physiology.

Molecular You analyzes a range of biomarkers to show health risks and what the user can do about it. Its preventive health assessment analyze not only genetics, but also metabolites, proteins, nutrients, and toxins to give the user the full picture. Then, it designs a personal diet and fitness plan to help the user stay healthy.

NTT Research, part of NTT Group (Nippon Telegraph and Telephone Corporation), is a Silicon Valley startup that conducts basic research and advances technologies that promote positive change. Currently, three labs are housed at NTT Research: the Physics and Informatics (PHI) Lab, the Cryptography and Information Security (CIS) Lab, and the Medical and Health Informatics (MEI) Lab. The organization aims to upgrade reality in three areas: 1) quantum information, neuro-science and photonics; 2) cryptographic and information security; and 3) medical and health informatics.

Biotwin develops an innovative technology to create digital twins for humans. It offers health professionals with data-driven and technological solutions to help them make better decisions and recommendations. Its software combines various health data with artificial intelligence to create personalized and comprehensive profiles, assisting patients to avail of healthcare facilities in time. The company was founded in 2018 and is based in Quebec City, Canada.

Q-State Biosciences is a precision medicine company creating new genetically targeted medicines for people living with nervous system disorders. The company's proprietary ResQueTM Platform incorporates a suite of technologies to map each patient’s unique genome to a genetic therapy that targets the root cause of disease.